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Reperfusion during acute myocardial infarction (AMI) remains the best treat-
ment for reducing infarct size. Postconditioning (PostC), applied at the onset 
of reperfusion, reduces myocardial infarction both in animals and humans. The 
objective of this study was to identify the time delay to apply postconditioning 
at reperfusion allowing to preserve a cardioprotection in the mouse myocar-
dium. This is a major issue for the management of AMI patients. 
Methods and results: Mice were subjected to 40 minutes ischemia/60 minutes 
reperfusion (IR60’). PostC protocols corresponding to repetitive ischemia 
(3 cycles: 1 minute ischemia - 1 minute reperfusion) were applied during early 
reperfusion at various time durations Ҟt) after re- opening the coronary artery 
(t=10 sec, 1, 5, 10, 15, 20, 30 and 45 minutes) (PostCt). 
Infarct size/AR was reduced by 71% in PostC1 compared to IR60’ mice 
(p<0.0001). There was a linear correlation (r2=0.91) between infarct size and t 
indicating that the cardioprotective effect of delayed postconditioning was pro-
gressively attenuated when t time increased. The protective effect of PostC1 
and PostC15 was still effective when the duration of reperfusion was prolonged 
to 24 hours (IR24h), (PostC1 and PostC15 versus IR24h; P=0.001). Similar 
results were obtained for internucleosomal DNA fragmentation and LDH release. 
Conclusions: This study in our in vivo mouse model of myocardial IR 
shows for the ¿ rst time that delaying the intervention of postconditioning to 
30 minutes does not abrogate the cardioprotective effect of PostC. This ¿ nding 
evidences that the time window of protection afforded by PostC may be larger 
than initially reported.
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Background: Myocardial infarction leads to heart failure and death. 
Ischemic preconditioning (PreC) and postconditioning (PostC) reduce infarct 
size in animal models and humans. The aim of our transcriptomic approach 
was to compare the gene pro¿ les regulated upon PreC and PostC and to inves-
tigate the role of Zac1, the only apoptosis- related gene jointly regulated upon 
PreC and PostC, against ischemia- reperfusion (IR) injury in vivo.
Methods and results: C57BL/6 mice were submitted to myocardial IR 
injury, PreC and PostC. 
mRNAs were extracted from the left ventricles and hybridized to pange-
nomic DNA microarray (16,463 mouse genes). Only 5 out of 16,463 screened 
genes were jointly regulated by PreC and PostC. Zac1 was the only apoptosis- 
related gene jointly down regulated upon PreC and PostC.
Quantitative real time RT- PCR and immunochemistry con¿ rmed that Zac1 
expression in the left ventricle was down regulated both at the transcrip-
tional and the proteomic levels upon PreC and PostC. Zac1- /- mutant mice 
(n=7) developed smaller infarcts (- 54%) than Zac1+/+ littermates (n=8) and 
decreased apoptosis (- 61.7%) in the ischemic part of the left ventricle when 
submitted to IR injury. Moreover those mutants showed in control conditions a 
53.9%- decrease in ventricular mRNA of Daxx, a pro- apoptotic protein playing 
a key role in ischemia- reperfusion injuries.
Conclusion: Our transcriptomic approach shows for the ¿ rst time that Zac1 is 
down regulated both at the transcriptional and protein levels upon PreC and PostC 
in WT mice. Moreover, inactivation of Zac1 in vivo is associated with decreased 
amount of Daxx transcripts and, upon IR injury, decreased infarct size and apop-
tosis. Altogether, our study shows that Zac1 plays a key role during cardioprotec-
tion against IR- injury. Our results also support the concept that cardioprotection 
regulates a network of interacting proapoptotic genes including Zac1 and Daxx.
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Objective: We aimed to develop a new model for ischemia reperfusion study: 
the organotypic culture. In this model, normal cell- cell interactions are main-
tained and the isolation procedure does not select a certain population of cells. 
Method: Organotypic heart slices (200m, vibratom, Leica) were obtained 
from left ventricle of heart rat or mouse. After 2 to 5 days culture, slices were 
submitted to a sequence of 4 hours ischemia following by 24 hours reperfu-
sion (I/R). Thereafter, we tested the cardioprotection (MTT test) in this orga-
notypic tissue heart model by applying an ischemic postconditioning (Post- C, 
3 cycles of 7min I/R), or a pharmacological Post- C (by using Cyclosporine A 
(CsA), at 200 and 500 nM), or by assessing the effect of tissue inhibitor of 
métalloproteinases- 1 (TIMP- 1, at 250nM, 500nM, 1μM and 2μM)), a poten-
tial cardioprotective agent. (N=8/group). 
Results: The MTT test revealed that the ischemic post- C and CsA (500 nM) 
increased the viability of heart slices by approximately 50% as compared with 
control. In addition it was observed a dose- effect of TIMP- 1, showing a signi-
¿ cant increase of the viability of the slices, at the concentration of 1 and 2 μM 
(respectively increase by 29 and 36%). 
Conclusion: Our results showed the interest of this new model and its possi-
bility of application for ischaemia- reperfusion study. Organotypic culture appears 
to be an intermediate model between the cellular culture and the whole organ.
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Background and Goal of Study: Administration of argon before pro-
longed coronary artery occlusion and reperfusion induces preconditioning 
(Anesth Analg. 2007;105(3): 562- 9). From a clinical point of view the ques-
tion arises whether argon application after the ischemic episode induces post-
conditioning. The aims of this study were 1) to test this effect, 2) examine the 
role of PI3K/Akt pathway, Extracellular signal- regulated kinase 1 and 2 (ERK 
1/2) and mitochondrial permeability transition pore (mPTP) in argon- induced 
postconditioning.
Methods: After the approval of local medical ethics committee, right atrial 
appendages were obtained during cannulation for CPB from patients sche-
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duled for routine cardiac surgery. The force of contraction (34°C, 1 Hz) of 
right atrial trabeculae was recorded during 30min hypoxia followed by 60min 
reoxygenation. 70% argon was administered administered for 2min before and 
3min after reoxygenation alone or in presence of Wortmannin (a PI3K inhi-
bitor), PD98059 (an ERK 1/2 antagonist), Atractyloside (a mPTP opener). The 
results are expressed in% of baseline. The force of contraction at the end of 
60 min reoxygenation period (FoC60) was compared (mean ± SD) between the 
groups by a variance analysis.
Results: Argon (FoC60=86±5% of baseline) signi¿ cantly enhanced the 
recovery of force after 60min of reoxygenation as compared with the 
Control (FoC60=49±7%). Wortmannin, PD98059, Atractyloside abolished 
argon- induced postconditioning (respectively FoC60=54±%; 65±2%; 57±10%; 
P<0.001 vs. argon). Administration of inhibitors alone has no signi¿ cant effect 
on the FoC60 as compared with Control.
Conclusions: The present study demonstrates for the ¿ rst time that argon 
applied brieÀ y during early reoxygenation is able to induce postconditioning 
in isolated human myocardium, and is mediated mediated by activation of 
PI3K and ERK 1/2, and inhibition of mPTP.
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Pharmacological postconditionning (PPostC) strategies, that limit lethal 
reperfusion injury, have a major clinical potential in acute myocardial infarc-
tion. A bolus injection of Cyclosporine A (CsA) or Bradykinin (BK) at reper-
fusion reduces myocardial infarct size (IS) in mouse by inhibiting the opening 
of the mitochondrial Permeability Transition Pore (mPTP) to trigger their car-
dioprotection (CP) effects during ischemia- reperfusion (IR). We investigate 
for the ¿ rst time whether in mouse BK is involved in the CP afforded against 
IR by CsA using Tissue Kallikrein de¿ cient mice (TK- /- ) lacking BK and their 
wild- type littermate (TK+/+). 
A branch of the left main coronary artery was reversibly ligated to produce 
30- min- ischemia followed by reperfusion (120min), after which the degree 
of IS (as a% of area at risk, AAR) was assessed. TK+/+ and TK- /-  male mice 
were divided in 2 groups receiving 5min before the reperfusion either the 
vehicule (ct) or 10mg/kg of CsA. As expected, CsA (10mg/kg) reduced IS 
(IS/AAR CtTK+/+=35.4±3.4% vs Csa- TK+/+ IS/AAR=13.6±2.5%, p=0.001). 
Interestingly, CsA is unable to reduce the IS in TK- /-  mice (IS/AAR CtTK- 
/- =31.8±6.8%, vs IS/AR CsATK- /- =29.8±6.1%) suggesting that the protective 
effects of CsA are abolished in absence of the TK. Investigating the mito-
chondria functions, we demonstrated that TK presence does not impact on 
mitochondrial membrane potential or oxidative phosphorylation. We however 
con¿ rmed that CsA bolus is able to inhibit the mPTP opening in TK+/+ mice 
while the CsA administration is unable to do so in TK- /-  mice.
While still investigating the molecular mechanisms of CsA lack of ef¿ cacy 
in TK- /-  mice, the present study demonstrate for the ¿ rst time that null expres-
sion of TK abrogates the CP effects of a PPostC afforded by a CsA bolus prior 
myocardial reperfusion in TK+/+ mice. Furthermore, we demonstrate that this 
loss of reactivity to CsA injection is due to mPTP loss of sensitivity to CsA.
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Background: Mitochondria play a critical role in deciding the fate of car-
diomyocytes subjected to hypoxia- reoxygenation (H/R) injury. The occur-
rence of a sudden change in the permeability of the mitochondrial membranes 
(mitochondrial permeability transition pore, PTP) is involved in H/R injury. 
Cyclophilin- D (CyP- D) is a major regulatory component of the PTP. Recently, 
we have demonstrated that rotenone, a complex I inhibitor, is a more potent 
PTP inhibitor than CsA in various cell types. These results are consistent with 
a PTP- regulatory interaction between CyP- D and complex I. 
Objective: Our aim was to study whether CyP- D inhibition and/or complex 
I inhibition reduce(s) cell death by modulating mPTP opening. 
Methods: Isolated adult mice cardiomyocytes (Wild Type (WT) and CyP- D 
KO) were submitted to 30min of hypoxia followed by 120min of reoxyge-
nation. Cell death and PTP opening (using Calcein- CoCl2 technique) were 
followed in time lapse À uorescence microscopy. Preconditioning (PreC) and 
postconditioning (PostC), using CsA (1M) and/or rotenone (1M) were per-
formed. Calcium retention capacity following CsA and/or rotenone treatments 
in isolated cardiac mitochondria and permeabilized cardiomyocytes was also 
examined.
Results: CsA- pre and postconditioning decreased cell death in WT cardio-
myocytes (to 38±3% and 37±4% respectively Vs. Control: 61±7%). After H/R 
CyP- KO cardiomyocytes were as resistant as CsA- treated WT cardiomyo-
cytes with cell death averaging 40±3%. Inhibition of complex I by rotenone 
in PreC and PostC protocols had no signi¿ cant effect on cell death and mPTP 
opening in WT cardiomyocytes. Interestingly, rotenone using in PreC poten-
tialized the protection (23±1% vs. control 40±3%) and ampli¿ ed the delay of 
PTP opening (40±3min vs. control 31.5±1min) conferred by the genetic inhi-
bition of CyP- D but not in PostC. 
Conclusion: Our data suggest that inhibition of complex I prevent cardio-
myocytes death after H/R in a CyP- D dependant manner.
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Introduction: Obstructive sleep apnea (OSA) characterized by chronic 
intermittent hypoxia (IH) is an important risk factor for cardiovascular mor-
bidity and mortality. We have previously demonstrated that oxidative stress is 
involved in the hypertension and the hypersensibility to myocardial infarction 
induced by IH. Knowing the antioxidant activity of atorvastatin, the aim of 
this study was to evaluate the bene¿ cial effects of this treatment against dele-
terious cardiovascular consequences of IH.
Methods: Male Wistar rats were exposed to 14 days of IH (cyclic 21- 5% 
FiO2, 60s cycle, 8h/day) or normoxie (N) and received 10mg.kg- 1.day- 1 of ator-
vastatin or its vehicle by intraperitoneal injection. After 14 days of exposure and 
treatment, mean arterial blood pressure (MABP) was measured before isolated 
hearts were submitted to an ischemia reperfusion (I/R) protocol. Oxidative stress 
was quanti¿ ed in myocardial tissue by measuring the dihydroethidium (DHE) 
level, p47- phox expression (the cytosolic protein required for the activation of 
the NADPH oxidase) and superoxide dismutase (SOD) activity.
Results: MABP was signi¿ cantly increased by IH exposure 
(132.7±3.7mmHg in IH group vs 119.8±4.8mmHg in N group). Likewise, 
chronic IH aggravated myocardial susceptibility to infarction (infarct sizes in 
percent of ventricles, 53.0±12.7% in IH group vs 41.0±7.8% in N group) and 
increased cardiac oxidative stress. These deleterious effects of IH were signi-
¿ cantly prevented by atorvastatin treatment, which was able to abolish the 
increased MABP and infarct size induced by HI. Atorvastatin also prevented 
the IH- induced increase in DHE level and p47- phox expression.
Conclusion: These results suggest that atorvastatin prevented deleterious 
cardiovascular consequences of IH. This atorvastatin protective effect might 
be due to its antioxidative property.
Keywords: Intermittent hypoxia, Myocardial infarction, Oxidative stress, 
Atorvastatin, Rats.
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